Physician

Steven B Newman, MD

According to 2025 Medicare claims, Steven Newman, MD (NPI: 1750370755) practices internal medicine in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34105-5020. Newman is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Newman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,088 traditional Medicare patients, billed 695,013 HCPCS/CPT codes, and received $11,973,463 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,504 prescription claims across 517 beneficiaries totaling $9,390,655 in drug costs, led by Revlimid (Lenalidomide). DME data shows 104 claims. Open Payments data shows 199 records totaling $4,580. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,824,182 to $11,973,463. Similarly, Part D prescription costs have moved sharply higher in recent years, from $939,222 to $9,390,655. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $10,478 to $7,487.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,136	153,030	$1,824,182
2016	1,576	311,156	$3,998,390
2017	1,621	279,391	$4,587,099
2018	1,767	391,218	$5,870,813
2019	2,076	550,108	$7,978,230
2020	2,262	664,703	$9,772,289
2021	2,181	545,593	$8,624,245
2022	2,029	585,446	$9,179,208
2023	2,047	708,108	$10,868,149
2024	2,088	695,013	$11,973,463

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	312	1,307	$939,222
2016	334	1,633	$2,112,068
2017	329	1,927	$3,171,865
2018	398	2,110	$4,234,024
2019	462	2,330	$4,847,871
2020	519	2,568	$5,184,036
2021	515	2,476	$6,326,325
2022	568	2,708	$8,161,821
2023	543	2,487	$6,890,535
2024	517	2,504	$9,390,655

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	126	$9,207
2016	N/R	112	$24,567
2017	24	87	$18,000
2018	11	64	$8,751
2019	N/R	57	$6,102
2020	38	150	$12,047
2021	27	149	$9,092
2022	27	166	$43,689
2023	N/R	109	$62,432
2024	N/R	104	$55,788

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,234	3,525	$97
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	404	512	$13
96372	Injection of drug or substance under skin or into muscle	444	1,611	$11
36415	Insertion of needle into vein for collection of blood sample	1,583	5,178	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,536	5,447	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	125	3,500	$2,313,139
Jakafi	Ruxolitinib Phosphate	60	1,780	$760,011
Pomalyst	Pomalidomide	38	1,057	$717,723
Ibrance	Palbociclib	39	1,085	$564,767
Kisqali	Ribociclib Succinate	30	833	$469,706

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	17	$48,522
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$3,532
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$1,488
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$898
J8521	Capecitabine, oral, 500 mg	N	N/R	20	$872

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	199	$4,580	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven B. Newman, MD?

Tedicare shows public-source Medicare data for Steven B. Newman, MD (NPI 1750370755), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven B. Newman, MD have ACO affiliation data?

Steven B. Newman, MD is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Steven B. Newman, MD?

Steven B. Newman, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Steven B. Newman, MD have Open Payments data?

Steven B. Newman, MD has 199 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.